Seoul Pharma Co. Ltd (018680) — Free Cash Flow Generation Index
Seoul Pharma Co. Ltd (018680) has a Free Cash Flow Generation Index of 0.96x as of June 2025. Free cash flow of ₩1.98 Billion represents 1% of operating cash flow (₩2.07 Billion). Explore 018680 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Free Cash Flow Generation Index (2009–2023)
Historical FCF Generation Index trend for Seoul Pharma Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see 018680 cash generation efficiency.
Annual Free Cash Flow Generation for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Free Cash Flow Generation Index for Seoul Pharma Co. Ltd. Check Seoul Pharma Co. Ltd (018680) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.64x | ₩3.37 Billion | ₩5.26 Billion | ₩1.89 Billion | ▼ -27.5% |
| 2020 | 0.88x | ₩5.07 Billion | ₩5.74 Billion | ₩671.25 Million | ▼ -16.2% |
| 2019 | 1.05x | ₩3.09 Billion | ₩2.93 Billion | ₩156.43 Million | ▼ -46.9% |
| 2015 | 1.98x | ₩2.82 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -28.5% |
| 2014 | 2.77x | ₩4.10 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -5.9% |
| 2012 | 2.95x | ₩27.17 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +39.1% |
| 2011 | 2.12x | ₩10.29 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -64.4% |
| 2009 | 5.95x | ₩7.34 Billion | ₩1.23 Billion | ₩6.11 Billion | — |